Marie Lodén

Summary

Affiliation: ACO HUD AB
Country: Sweden

Publications

  1. ncbi Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration
    Marie Lodén
    ACO HUD AB, Box 622, SE 194 26 Upplands Väsby, Sweden
    Int J Pharm 284:23-30. 2004
  2. ncbi The clinical benefit of moisturizers
    M Loden
    ACO HUD AB, Stockholm, Sweden
    J Eur Acad Dermatol Venereol 19:672-88; quiz 686-7. 2005
  3. ncbi Facial anti-wrinkle cream: influence of product presentation on effectiveness: a randomized and controlled study
    Marie Lodén
    ACO HUD NORDIC, Uppsala, Sweden
    Skin Res Technol 13:189-94. 2007
  4. ncbi Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm)
    M Loden
    Research and Development, ACO HUD AB, Box 542, S 18215 Danderyd, Stockholm, Sweden
    Br J Dermatol 140:264-7. 1999
  5. ncbi Novel method for studying photolability of topical formulations: a case study of titanium dioxide stabilization of ketoprofen
    Marie Lodén
    ACO HUD AB, Box 622, SE 194 26, Upplands Vasby, Sweden
    J Pharm Sci 94:781-7. 2005
  6. ncbi Irritation potential of bath and shower oils before and after use: a double-blind randomized study
    M Loden
    ACO HUD AB, SE 194 26 Upplands Väsby, Sweden
    Br J Dermatol 150:1142-7. 2004
  7. ncbi The irritation potential and reservoir effect of mild soaps
    Marie Lodén
    ACO HUD AB, Box 622, SE 194 26 Upplands Väsby, Sweden
    Contact Dermatitis 49:91-6. 2003
  8. ncbi Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders
    Marie Lodén
    ACO HUD AB, Stockholm, Sweden
    Am J Clin Dermatol 4:771-88. 2003
  9. ncbi The skin barrier and use of moisturizers in atopic dermatitis
    Marie Lodén
    Research and Development Department, ACO Hud, Sweden
    Clin Dermatol 21:145-57. 2003
  10. ncbi A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients
    Marie Lodén
    ACO HUD AB, Stockholm, Sweden
    Acta Derm Venereol 82:45-7. 2002

Detail Information

Publications16

  1. ncbi Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration
    Marie Lodén
    ACO HUD AB, Box 622, SE 194 26 Upplands Väsby, Sweden
    Int J Pharm 284:23-30. 2004
    ..A supersaturated formulation may well have been formed initially due to evaporation of ethanol...
  2. ncbi The clinical benefit of moisturizers
    M Loden
    ACO HUD AB, Stockholm, Sweden
    J Eur Acad Dermatol Venereol 19:672-88; quiz 686-7. 2005
    ..Patients and the society expect dermatologists and pharmacists to be able to recommend treatment for various dry skin conditions upon evidence-based medicine...
  3. ncbi Facial anti-wrinkle cream: influence of product presentation on effectiveness: a randomized and controlled study
    Marie Lodén
    ACO HUD NORDIC, Uppsala, Sweden
    Skin Res Technol 13:189-94. 2007
    ..A high-priced luxurious anti-wrinkle cream dispensed in its original packaging and in a neutral jar, were compared with the effects from a regular moisturizing face cream in a luxurious jar...
  4. ncbi Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm)
    M Loden
    Research and Development, ACO HUD AB, Box 542, S 18215 Danderyd, Stockholm, Sweden
    Br J Dermatol 140:264-7. 1999
    ..05). Thus, it seems that certain moisturizers could improve skin barrier function in atopics and reduce skin susceptibility to irritants. The mechanism and the clinical relevance need further investigation...
  5. ncbi Novel method for studying photolability of topical formulations: a case study of titanium dioxide stabilization of ketoprofen
    Marie Lodén
    ACO HUD AB, Box 622, SE 194 26, Upplands Vasby, Sweden
    J Pharm Sci 94:781-7. 2005
    ..Thus, surface-coated microparticles of titanium dioxide may well be of clinical benefit in protecting photolabile drug substances against sunlight...
  6. ncbi Irritation potential of bath and shower oils before and after use: a double-blind randomized study
    M Loden
    ACO HUD AB, SE 194 26 Upplands Väsby, Sweden
    Br J Dermatol 150:1142-7. 2004
    ..A large variety of shower and bath oils are claimed to be suitable for use on dry skin because of their mildness and because they deposit a protective oil film on the skin...
  7. ncbi The irritation potential and reservoir effect of mild soaps
    Marie Lodén
    ACO HUD AB, Box 622, SE 194 26 Upplands Väsby, Sweden
    Contact Dermatitis 49:91-6. 2003
    ..Subclinical skin damage can make the skin vulnerable to further irritation and delay recovery of chronic irritant contact dermatitis...
  8. ncbi Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders
    Marie Lodén
    ACO HUD AB, Stockholm, Sweden
    Am J Clin Dermatol 4:771-88. 2003
    ..The chemistry and function of dry skin and moisturizers is a challenging subject for the practicing dermatologist, as well as for the chemist developing these agents in the pharmaceutical/cosmetic industry...
  9. ncbi The skin barrier and use of moisturizers in atopic dermatitis
    Marie Lodén
    Research and Development Department, ACO Hud, Sweden
    Clin Dermatol 21:145-57. 2003
  10. ncbi A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients
    Marie Lodén
    ACO HUD AB, Stockholm, Sweden
    Acta Derm Venereol 82:45-7. 2002
    ..The study showed equal effects on skin dryness as judged by the patients and the dermatologist. In conclusion, a glycerin containing cream appears to be a suitable alternative to urea/sodium chloride in the treatment of atopic dry skin...
  11. ncbi Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis
    M Loden
    ACO HUD AB, Stockholm, Sweden
    Skin Res Technol 7:209-13. 2001
    ....
  12. ncbi Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin
    M Loden
    ACO HUD AB, Upplands Vasby, Sweden
    Acta Derm Venereol 80:412-5. 2000
    ..This finding may support the hypothesis that different types of skin abnormality should be treated according to the underlying damage...
  13. ncbi Treatment of surfactant-damaged skin in humans with creams of different pH values
    Izabela Buraczewska
    ACO HUD AB, Upplands Vasby, Sweden
    Pharmacology 73:1-7. 2005
    ..0 to a cream of pH 7.5 regarding promotion of skin barrier recovery, since no significant differences (p > 0.05) were found in transepidermal water loss, blood flow and skin capacitance between the treated areas...
  14. ncbi Differences among moisturizers in affecting skin susceptibility to hexyl nicotinate, measured as time to increase skin blood flow
    Celine Duval
    Department of Medicine, Occupational and Environmental Dermatology, Karolinska Institute, Stockholm, Sweden
    Skin Res Technol 9:59-63. 2003
    ..The aim of the present study was to compare the effect of two moisturizers on the skin permeability barrier, assessed as skin reactivity to a vasodilating substance...
  15. ncbi Effects of pretreatment with a urea-containing emollient on nickel allergic skin reactions
    Natalia Kuzmina
    Department of Medicine, Section of Dermatology and Venereology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden
    Acta Derm Venereol 85:9-12. 2005
    ..All control subjects had negative nickel tests. We concluded that the skin reactivity to nickel in nickel-sensitized patients is not significantly affected by use of the urea-containing moisturizer...
  16. ncbi Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics
    Marie Lodén
    Research and Development, ACO HUD NORDIC AB, Upplands Vasby, Sweden
    Acta Derm Venereol 87:485-92. 2007
    ..Lack of transparency increases the risk of consumers wasting money on cosmetics that do not deliver the desired effects. This may jeopardize public trust in the cosmetic industry...